Status:
NOT_YET_RECRUITING
Cohort of Neurovascular Diseases Treated in the Acute Phase and Followed at Lariboisière
Lead Sponsor:
Assistance Publique - Hôpitaux de Paris
Conditions:
Ischemic Stroke
Hemorrhagic Stroke
Eligibility:
All Genders
18-100 years
Brief Summary
Neurovascular diseases can cause ischaemic or haemorrhagic strokes. While the most common, such as atherosclerosis are widely studied, others are less well known, such as arterial dissections or cereb...
Eligibility Criteria
Inclusion
- Adult patients ≥18 years
- Patients admitted to the Neurovascular Intensive Care Unit with acute cerebrovascular disease OR Patients managed for acute cerebrovascular pathology with or without stroke by the Lariboisière neurology team.
- No opposition from the patient to the research and for patients under guardianship or guardianship or lack of capacity to object (severe impairment of cognitive functions, dementia, etc.), no opposition from the legal representative.
Exclusion
- Patient refusing to take part in the study or refusal by the legal representative in the case of patients under guardianship or curatorship
- Patient suffering from a rare neurovascular disease and being followed at the "Centre de référence des maladies vasculaires rares du cerveau et de l'oeil" (CERVCO)
Key Trial Info
Start Date :
September 1 2023
Trial Type :
OBSERVATIONAL
Allocation :
ESTIMATED
End Date :
September 1 2038
Estimated Enrollment :
5000 Patients enrolled
Trial Details
Trial ID
NCT06026696
Start Date
September 1 2023
End Date
September 1 2038
Last Update
September 7 2023
Active Locations (0)
Enter a location and click search to find clinical trials sorted by distance.
No Results Found
We couldn’t find results for the location/zipcode entered or within the selected range. Please check your input or adjust your search.